Founders exploring XAnge funding are looking at one of Europe's most experienced early-stage investors. XAnge is a Franco-German venture capital firm — the innovation brand of the Siparex group, a major French private equity house — with offices in Paris, Berlin and Brussels. It describes itself as a B Corp-certified investor that has backed more than 200 startups, with 120+ exits and five unicorns in its portfolio. The firm manages approximately €600 million in assets and has been investing in European technology since 2003.
Investment thesis: European game changers, from seed to scale
XAnge's thesis centres on founders who reinvent daily life and create lasting value for businesses and society. It focuses on three territories — digital, deeptech and impact — with recent priority sectors including digital health, decentralised finance, Web3, developer tools, bio-sourcing and bio-production. The firm leads or co-leads seed and Series A rounds across France, Germany, Austria, Belgium and Switzerland, and positions itself as a long-term partner rather than a transactional investor, supported by a "Startup Success" platform for business development, hiring and international expansion.
XAnge funding: cheque size and fund structure
XAnge closed its fourth early-stage fund, XAnge 4, at €220 million in 2022 — double the size of its previous fund. Ticket sizes run from €300,000 to €10 million, with around half of the fund reserved for follow-on investments. The firm also launched a dedicated Web3 vehicle, the Digital Ownership Fund, with a target raise of €80 million. Sectors in focus span digital consumer, enterprise and data, fintech, and deeptech, from pre-seed through early growth.
Notable portfolio
XAnge's track record includes some of Europe's best-known technology companies: Ledger (crypto hardware wallets), Odoo (open-source business software), Lydia (fintech) and Believe (music distribution). It counts six unicorns in its portfolio — Believe, Deposit Solutions, Ledger, Lydia, Odoo and Flink — and has supported two IPOs, Believe and Mister Spex. From XAnge 4, portfolio companies include WorkMotion (Series B), Pina Earth (seed, forest-carbon certification), Silvr, Greenly, Gitti and Qubit Pharmaceuticals.
Partners and team
The team is led by Managing Partner Cyril Bertrand, alongside Nicolas Rose, Alexis du Peloux and Nadja Bresous Mehigan (Partner, Impact), with Guillaume Meulle as Managing Partner and Valerie Bures heading the DACH region from Berlin. The firm describes its team as operator-led, with backgrounds in product development, startup scaling and enterprise SaaS.
How to apply for funding
XAnge's official website, xange.vc, is the firm's front door for founder outreach — reach out to the investment teams in Paris, Berlin or Brussels with a concise deck covering your team, traction, market and use of funds. XAnge favours founders with strong values and international ambition, so show clearly how your company can scale beyond its home market. Warm introductions via portfolio founders or co-investors are the most effective route in.
Why it matters for founders
XAnge suits Franco-German and broader European seed-to-Series-A startups in digital, deeptech and impact that want an investor with 20+ years of navigating tech cycles, a genuine pan-European network, and a B Corp ethos — particularly strong for fintech, Web3 and digital-health founders.